Skip to main content
English

Suche

  1. Home
  2. Suche

Webseiten-Inhalte

News ... der Vetmeduni Vienna unter der Leitung von Lukas Kenner wurde gezeigt, dass sich zwei unabhängige Pathologen nur bei jeder dritten Diagnose einig waren. Eine nun gemeinsam entwickelte, neue Computer-Software hilft dabei, künftig die diagnostische Sicherheit zu verdoppeln. Das ist das Ergebnis der... https://www.meduniwien.ac.at/web/index.php?id=131&L=3&tx_news_pi1%5Bnews%5D=2453&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Baction%5D=detail&cHash=52a1fac0bcf62182f433a1b923fc1c31
News ... der Vetmeduni Vienna unter der Leitung von Lukas Kenner wurde gezeigt, dass sich zwei unabhängige Pathologen nur bei jeder dritten Diagnose einig waren. Eine nun gemeinsam entwickelte, neue Computer-Software hilft dabei, künftig die diagnostische Sicherheit zu verdoppeln. Das ist das Ergebnis der... https://www.meduniwien.ac.at/web/ueber-uns/news/detail/?tx_news_pi1%5Bnews%5D=2453&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Baction%5D=detail&cHash=52a1fac0bcf62182f433a1b923fc1c31
Detailsite | MedUni Vienna ... individual pathologist. A study led by Lukas Kenner at the MedUni Vienna at the Clinical Institute of Pathology, as well as at the Ludwig Boltzmann Institute for Cancer Research (LBI-CR) and the VetMedUni Vienna, has demonstrated that two independent pathologists only agreed on one in three diagnoses. New... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/?tx_news_pi1%5Bnews%5D=2453&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Baction%5D=detail&cHash=52a1fac0bcf62182f433a1b923fc1c31
Detailsite | MedUni Vienna ... individual pathologist. A study led by Lukas Kenner at the MedUni Vienna at the Clinical Institute of Pathology, as well as at the Ludwig Boltzmann Institute for Cancer Research (LBI-CR) and the VetMedUni Vienna, has demonstrated that two independent pathologists only agreed on one in three diagnoses. New... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/new-technology-developed-to-diagnose-cancer-cells/?L=3
Detailsite | MedUni Vienna ... levels of this protein are associated with a lower likelihood of survival for breast cancer patients. "Our results reveal that the Ret enzyme (Ret kinase) may be an attractive and novel therapeutic target in selected groups of breast cancer patients,” says Lukas Kenner from the Clinical Institute of... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/?tx_news_pi1%5Bnews%5D=1504&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Baction%5D=detail&cHash=511bbddda2ee5b88b1950a226ae90a9f
Detailsite | MedUni Vienna ... levels of this protein are associated with a lower likelihood of survival for breast cancer patients. "Our results reveal that the Ret enzyme (Ret kinase) may be an attractive and novel therapeutic target in selected groups of breast cancer patients,” says Lukas Kenner from the Clinical Institute of... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/new-approach-in-the-treatment-of-breast-cancer/?L=3
Detailsite | MedUni Vienna ... occurs in children and young adults and so far has been difficult to treat. Now, a group led by Lukas Kenner from the MedUni Vienna and the Ludwig Boltzmann Institute, with assistance from Karoline Kollmann and Veronika Sexl from the Vienna University of Veterinary Medicine and an international group of researchers, has successfully treated a seriously ill ALCL patient with a specific PDGFR inhibitor. Says Kenner: “In just ten days, the 27-year-old patient was free from tumours and has been leading a completely normal life for more than 22 months. Without this treatment, the patient would most probably be... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/?tx_news_pi1%5Bnews%5D=1153&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Baction%5D=detail&cHash=919fb290da07a088c31a40eef773ee13
Detailsite | MedUni Vienna ... occurs in children and young adults and so far has been difficult to treat. Now, a group led by Lukas Kenner from the MedUni Vienna and the Ludwig Boltzmann Institute, with assistance from Karoline Kollmann and Veronika Sexl from the Vienna University of Veterinary Medicine and an international group of researchers, has successfully treated a seriously ill ALCL patient with a specific PDGFR inhibitor. Says Kenner: “In just ten days, the 27-year-old patient was free from tumours and has been leading a completely normal life for more than 22 months. Without this treatment, the patient would most probably be... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/success-in-the-treatment-of-aggressive-lymphatic-cancer/?L=3
Detailsite | MedUni Vienna ...All News [in German:] Biologin aus der Arbeitsgruppe von Lukas Kenner für Forschungsarbeit über Lymphom ausgezeichnet [in German:] (Wien, 13-06-2014)Daniela Laimer-Gruber wurde mit dem Novartis-Preis der Deutschen Gesellschaft für Pathologie 2014 ausgezeichnet. Die Biologin aus der Arbeitsgruppe um Lukas Kenner, Klinisches Institut für Pathologie der MedUni Wien und stellvertretender Leiter des Ludwig Boltzmann Instituts für Krebsforschung, überzeugte die Jury mit ihrer eingereichten Dissertation „PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas". Die... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/?tx_news_pi1%5Bnews%5D=2344&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Baction%5D=detail&cHash=ba630ff85570ac9cec52bfc8c0ade24f
News ...Alle News Biologin aus der Arbeitsgruppe von Lukas Kenner für Forschungsarbeit über Lymphom ausgezeichnet (Wien, 13-06-2014) Daniela Laimer-Gruber wurde mit dem Novartis-Preis der Deutschen Gesellschaft für Pathologie 2014 ausgezeichnet. Die Biologin aus der Arbeitsgruppe um Lukas Kenner, Klinisches Institut für Pathologie der MedUni Wien und stellvertretender Leiter des Ludwig Boltzmann Instituts für Krebsforschung, überzeugte die Jury mit ihrer eingereichten Dissertation „PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas". Die Preisverleihung fand... https://www.meduniwien.ac.at/web/index.php?id=131&L=3&tx_news_pi1%5Bnews%5D=2344&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Baction%5D=detail&cHash=ba630ff85570ac9cec52bfc8c0ade24f